• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在亚太地区实施中性对待艾滋病毒的方法。

Implementing a Status-Neutral Approach to HIV in the Asia-Pacific.

机构信息

Institute of HIV Research and Innovation, 319 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand.

Mplus Foundation, 142 Chiang Mai Hod Road, Muang, Chiang Mai, 50200, Thailand.

出版信息

Curr HIV/AIDS Rep. 2020 Oct;17(5):422-430. doi: 10.1007/s11904-020-00516-z.

DOI:10.1007/s11904-020-00516-z
PMID:32725317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7497381/
Abstract

PURPOSE OF REVIEW

Globally, "undetectable equals untransmittable (U=U)" and "pre-exposure prophylaxis (PrEP)" have become crucial elements in HIV treatment and prevention programs. We reviewed the implementation of U=U and PrEP among countries in the Asia-Pacific region.

RECENT FINDINGS

U=U and PrEP uptakes were limited and slow in the Asia-Pacific. Inadequate knowledge among health care practitioners and pervasive stigma towards individuals living with HIV and their sexual lives are key barriers for the integration of U=U into clinical practice. Paternalistic and hierarchical health care systems are major obstacles in PrEP implementation and scale-up. Countries with the most advanced PrEP implementation all use community-based, nurse-led, and key population-led service delivery models. To advance U=U and PrEP in the Asia-Pacific, strategies targeting changes to practice norm through wide-scale stakeholders' training and education, making use of online health care professional influencers, and utilizing financial mechanism should be further explored through implementation research.

摘要

目的综述

在全球范围内,“检测不到等于不传播(U=U)”和“暴露前预防(PrEP)”已成为 HIV 治疗和预防规划的重要内容。我们对亚太地区国家实施 U=U 和 PrEP 的情况进行了综述。

最近的发现

在亚太地区,U=U 和 PrEP 的采用率有限且缓慢。医护人员知识不足,对 HIV 感染者及其性生活的普遍污名化,是将 U=U 纳入临床实践的主要障碍。家长式和等级制的医疗保健系统是 PrEP 实施和扩大的主要障碍。实施 PrEP 最先进的国家均采用以社区为基础、护士主导和重点人群主导的服务提供模式。为了在亚太地区推进 U=U 和 PrEP,应通过实施研究进一步探索通过广泛的利益攸关方培训和教育、利用在线医疗保健专业影响者以及利用财务机制来改变实践规范的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69a7/7497381/d1813c48f4a5/11904_2020_516_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69a7/7497381/d1813c48f4a5/11904_2020_516_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69a7/7497381/d1813c48f4a5/11904_2020_516_Fig1_HTML.jpg

相似文献

1
Implementing a Status-Neutral Approach to HIV in the Asia-Pacific.在亚太地区实施中性对待艾滋病毒的方法。
Curr HIV/AIDS Rep. 2020 Oct;17(5):422-430. doi: 10.1007/s11904-020-00516-z.
2
PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers.亚太地区的暴露前预防实施:机遇、实施情况与障碍
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21119. doi: 10.7448/IAS.19.7.21119. eCollection 2016.
3
A review of HIV pre-exposure prophylaxis (PrEP) programmes by delivery models in the Asia-Pacific through the healthcare accessibility framework.通过医疗可及性框架对亚太地区基于不同提供模式的 HIV 暴露前预防(PrEP)项目进行的回顾。
J Int AIDS Soc. 2020 Jul;23(7):e25531. doi: 10.1002/jia2.25531.
4
The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review.目前用于预防 HIV 的暴露前预防服务提供模式:范围综述。
BMC Health Serv Res. 2020 Jul 31;20(1):704. doi: 10.1186/s12913-020-05568-w.
5
Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.将暴露前预防付诸实践:从美国早期采用者提供艾滋病毒暴露前预防及相关护理的第一手经验中吸取的教训。
PLoS One. 2016 Jun 15;11(6):e0157324. doi: 10.1371/journal.pone.0157324. eCollection 2016.
6
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework.理解比利时 HIV 诊所中 PrEP 服务提供中的适应性反应:使用实施科学框架的多个案例研究。
J Int AIDS Soc. 2024 Jul;27 Suppl 1(Suppl 1):e26260. doi: 10.1002/jia2.26260.
7
A rapid review of pre-exposure prophylaxis for HIV in the Asia-Pacific region: recommendations for scale up and future directions.亚太地区HIV暴露前预防的快速审查:扩大规模的建议及未来方向
Sex Health. 2021 Mar;18(1):31-40. doi: 10.1071/SH20058.
8
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.通过家庭医生和性健康诊所护士分散提供艾滋病毒暴露前预防(PrEP):一项传播与实施研究方案
BMC Health Serv Res. 2018 Jul 3;18(1):513. doi: 10.1186/s12913-018-3324-2.
9
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.美国卫生保健提供者在 HIV 暴露前预防措施方面面临的障碍:系统评价。
AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28.
10
"I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.“我只是认为存在风险”,在肯尼亚的血清不一致关系中,卫生提供者和 HIV 阴性伴侣对无法检测到等于无法传播(U=U)的理解。
J Int AIDS Soc. 2020 Mar;23(3):e25466. doi: 10.1002/jia2.25466.

引用本文的文献

1
Ehealth interactive intervention in promoting safer sex among men who have sex with men.电子健康互动干预对促进男男性行为者的安全性行为的作用
NPJ Digit Med. 2024 Nov 9;7(1):313. doi: 10.1038/s41746-024-01313-3.
2
Navigating the Viral Divide: Sexual and Gender Minority Community Perspectives on Treatment as Prevention.跨越病毒鸿沟:性少数和性别少数群体对治疗即预防的观点。
AIDS Educ Prev. 2023 Oct;35(5):406-419. doi: 10.1521/aeap.2023.35.5.406.
3
Outcomes of a model for re-testing HIV-negative index contacts in Sedibeng, South Africa.

本文引用的文献

1
Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.评估泰国男男性行为者和跨性别女性的暴露前预防计划:从艾滋病预防阶梯的角度学习。
J Int AIDS Soc. 2020 Jun;23 Suppl 3(Suppl 3):e25540. doi: 10.1002/jia2.25540.
2
Give the community the tools and they will help finish the job: key population-led health services for ending AIDS in Thailand.给社区提供工具,他们将助力完成这项工作:泰国由关键人群主导的终结艾滋病健康服务。
J Int AIDS Soc. 2020 Jun;23(6):e25535. doi: 10.1002/jia2.25535.
3
Fast-tracking the end of HIV in the Asia Pacific region: domestic funding of key population-led and civil society organisations.
南非塞迪本对HIV阴性索引接触者进行重新检测的模型结果。
South Afr J HIV Med. 2023 May 29;24(1):1482. doi: 10.4102/sajhivmed.v24i1.1482. eCollection 2023.
4
The future of HIV testing in eastern and southern Africa: Broader scope, targeted services.东非和南非的 HIV 检测的未来:更广泛的范围,有针对性的服务。
PLoS Med. 2023 Mar 14;20(3):e1004182. doi: 10.1371/journal.pmed.1004182. eCollection 2023 Mar.
5
Web-Based Harm Reduction Intervention for Chemsex in Men Who Have Sex With Men: Randomized Controlled Trial.基于网络的男男性行为人群化学物质使用相关性行为危害减少干预:随机对照试验
JMIR Public Health Surveill. 2023 Jan 5;9:e42902. doi: 10.2196/42902.
6
The ethical imperative to reduce HIV stigma through community-engaged, status-neutral interventions designed with and for transgender women of colour in the United States.通过社区参与、状态中立的干预措施,减少艾滋病毒污名化的道德必要性,这些措施是为美国的跨性别有色人种女性设计并面向她们的。
J Int AIDS Soc. 2022 Jul;25 Suppl 1(Suppl 1):e25907. doi: 10.1002/jia2.25907.
7
Factors associated with testing for HIV and other sexually transmitted infections in men who have sex with men and transgender women in Bangkok, Thailand.与在泰国曼谷与男男性行为者和跨性别女性进行艾滋病毒和其他性传播感染检测相关的因素。
AIDS Res Ther. 2022 Jun 21;19(1):25. doi: 10.1186/s12981-022-00449-0.
8
Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?扩大艾滋病毒暴露前预防(PrEP)的获取途径:护士应该做这项工作吗?
Lancet HIV. 2022 May;9(5):e363-e366. doi: 10.1016/S2352-3018(22)00006-6. Epub 2022 Mar 28.
9
Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria.关于不同抗逆转录病毒治疗(ART)恢复标准的 HIV 缓解试验中分析性治疗中断(ATI)的态度。
AIDS Behav. 2022 May;26(5):1504-1516. doi: 10.1007/s10461-021-03504-5. Epub 2022 Jan 8.
10
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding.通塞·帕莫兹迪:制定综合策略,支持妊娠和哺乳期妇女坚持接受抗逆转录病毒疗法和 HIV 暴露前预防。
PLoS One. 2021 Jun 25;16(6):e0253280. doi: 10.1371/journal.pone.0253280. eCollection 2021.
在亚太地区加速终结艾滋病:关键人群主导和民间社会组织的国内资金投入。
Lancet HIV. 2020 May;7(5):e366-e372. doi: 10.1016/S2352-3018(20)30077-1.
4
Discordance between self-perceived and actual risk of HIV infection among men who have sex with men and transgender women in Thailand: a cross-sectional assessment.泰国男男性行为者和跨性别女性自我感知与实际艾滋病毒感染风险之间的差异:一项横断面评估。
J Int AIDS Soc. 2019 Dec;22(12):e25430. doi: 10.1002/jia2.25430.
5
Perceived risk versus objectively measured risk of HIV acquisition: a cross-sectional study among HIV-negative individuals in Serodiscordant partnerships with clients attending an Urban Clinic in Uganda.感知风险与客观测量的 HIV 感染风险:乌干达一家城市诊所中与 HIV 阴性的性伴进行性接触的 HIV 阳性客户的横断面研究。
BMC Public Health. 2019 Nov 29;19(1):1591. doi: 10.1186/s12889-019-7929-0.
6
Discordance in Objective and Self-perceived HIV Risk: A Potential Barrier to Pre-exposure Prophylaxis in Young Gay and Bisexual Men.客观与自我认知的HIV风险不一致:年轻男同性恋者和双性恋男性进行暴露前预防的潜在障碍。
J Assoc Nurses AIDS Care. 2020 Jan-Feb;31(1):103-109. doi: 10.1097/JNC.0000000000000137.
7
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.在接受抑制性抗逆转录病毒疗法的 HIV 阳性伴侣的血清学不同的男同性恋伴侣中,无保护性行为传播 HIV 的风险(PARTNER):一项多中心、前瞻性、观察性研究的最终结果。
Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2.
8
Global PrEP roll-out: recommendations for programmatic success.全球普及预防:项目成功的建议。
Lancet HIV. 2019 Feb;6(2):e137-e140. doi: 10.1016/S2352-3018(19)30002-5. Epub 2019 Jan 16.
9
Lay provider HIV testing: A promising strategy to reach the undiagnosed key populations in Vietnam.基层提供者 HIV 检测:越南发现未诊断关键人群的有前景策略。
PLoS One. 2018 Dec 31;13(12):e0210063. doi: 10.1371/journal.pone.0210063. eCollection 2018.
10
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.尽管对每日暴露前预防治疗高度依从,但仍获得对替诺福韦敏感、对恩曲他滨耐药的艾滋病毒:一例病例报告。
Lancet HIV. 2018 Nov 29. doi: 10.1016/S2352-3018(18)30288-1.